ARTICLE | Clinical News
Xyntha recombinant Factor VIII regulatory update
August 16, 2010 7:00 AM UTC
FDA approved an sBLA from Pfizer for a prefilled, dual-chamber syringe formulation of Xyntha recombinant Factor VIII to control and prevent bleeding episodes and for surgical prophylaxis in patients w...